Movement Alert|Elevance Health Intraday Rise 3.14% in Regular Trading, Managed Care Rebounds as Selling Pressure Eases

Market Focus
11/20

On November 20, Elevance Health recorded an Intraday Rise of 3.14% in Regular Trading, trading at $399.12 per share, with turnover of $50.2617 million.

The clearest catalyst in recent market coverage is a rebound across managed care stocks after several sessions of policy-driven selling tied to tougher Medicare Advantage and Medicaid oversight proposals.

Recent coverage showed peers also recovering, including UnitedHealth rising 3.08%, Humana rising 3.66%, HealthEquity rising 1.08%, and Molina Healthcare rising 0.11%, indicating a sector-wide relief move after the earlier CMS audit proposal had pressured valuations. Supporting sentiment also came from favorable analyst positioning, including a maintained Buy rating with a $520 target and an upgrade to Buy. Earlier company fundamentals remained constructive as well, with Elevance Health reporting adjusted EPS of $6.99, revenue of $50.44 billion, and raising full-year adjusted EPS guidance to at least $29.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10